{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:12:53Z","timestamp":1781817173398,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.anai.2010.10.012","type":"journal-article","created":{"date-parts":[[2010,11,21]],"date-time":"2010-11-21T04:21:37Z","timestamp":1290313297000},"page":"62-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks"],"prefix":"10.1016","volume":"106","author":[{"given":"Richard L.","family":"Wasserman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn J.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Againdra K.","family":"Bewtra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hurewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Kiessling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz-Otto","family":"Keinecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2010.10.012_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/1744666X.4.1.13","article-title":"Pasteurized C1 inhibitor concentrate in hereditary angioedema: pharmacology, safety, efficacy and future directions","volume":"4","author":"Bork","year":"2008","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.anai.2010.10.012_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clim.2004.05.007","article-title":"The pathophysiology of hereditary angioedema","volume":"114","author":"Davis","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.anai.2010.10.012_bib3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1126\/science.173.3996.553","article-title":"C1 inhibitor: evidence for decreased hepatic synthesis in hereditary angioneurotic edema","volume":"173","author":"Johnson","year":"1971","journal-title":"Science"},{"key":"10.1016\/j.anai.2010.10.012_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molmed.2008.12.001","article-title":"C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress","volume":"15","author":"Cugno","year":"2009","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.anai.2010.10.012_bib5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00005792-199207000-00003","article-title":"Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients","volume":"71","author":"Agostoni","year":"1992","journal-title":"Medicine (Baltimore)"},{"issue":"suppl 2","key":"10.1016\/j.anai.2010.10.012_bib6","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/S1081-1206(10)60584-4","article-title":"Hereditary angioedema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema","volume":"100","author":"Bowen","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2010.10.012_bib7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1398-9995.2007.01577.x","article-title":"Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angio-oedema","volume":"63","author":"Bork","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2010.10.012_bib8","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJM199606203342503","article-title":"Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate","volume":"334","author":"Waytes","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anai.2010.10.012_bib9","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jaci.2006.01.002","article-title":"Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency","volume":"117","author":"Levi","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2010.10.012_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0161-5890(01)00040-2","article-title":"C1-inhibitor deficiency and angioedema","volume":"38","author":"Carugati","year":"2001","journal-title":"Mol Immunol"},{"key":"10.1016\/j.anai.2010.10.012_bib11","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1517\/14656566.8.18.3173","article-title":"The use of plasma-derived C1 inhibitor in the treatment of hereditary angioedema","volume":"8","author":"Cicardi","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.anai.2010.10.012_bib12","first-page":"S96","article-title":"Virus safety of current plasma-derived C1-INH: the Aventis Behring experience","volume":"114","author":"Juers","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2010.10.012_bib13","first-page":"A96","article-title":"An integrated approach to effective pathogen reduction for a plasma-derived C1 inhibitor concentrate","volume":"28","author":"Gr\u00f6ner","year":"2008","journal-title":"H\u00e4mostaseologie"},{"key":"10.1016\/j.anai.2010.10.012_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.transci.2003.08.006","article-title":"Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert P) in hereditary angioedema: a review","volume":"29","author":"de Serres","year":"2003","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.anai.2010.10.012_bib15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaci.2009.07.017","article-title":"Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks","volume":"124","author":"Craig","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2010.10.012_bib16","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/j.1537-2995.2005.00602.x","article-title":"Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema","volume":"45","author":"Bork","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.anai.2010.10.012_bib17","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.molimm.2006.04.020","article-title":"C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema: strong correlation with the severity of disease in C1-INH concentrate na\u00efve patients","volume":"44","author":"Varga","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.anai.2010.10.012_bib18","unstructured":"Farkas H, Varga L, Csuka L, et al. The presence and frequency of IgM type antibodies to C1-inhibitor (C1-INH) are not related to the administration of C1-INH concentrate in patients with hereditary angioedema (HAE). Paper presented at: 29th Congress of the European Academy of Allergy and Clinical Immunology; June 5-9, 2010; London, England. Poster abstract 1178-P."},{"key":"10.1016\/j.anai.2010.10.012_bib19","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1572-0241.2006.00492.x","article-title":"Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency","volume":"101","author":"Bork","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.anai.2010.10.012_bib20","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMcp0803977","article-title":"Clinical practice: hereditary angioedema","volume":"359","author":"Zuraw","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anai.2010.10.012_bib21","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.1537-2995.1998.38698326333.x","article-title":"A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema","volume":"38","author":"Kunschak","year":"1998","journal-title":"Transfusion"},{"key":"10.1016\/j.anai.2010.10.012_bib22","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jaci.2007.06.026","article-title":"Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy","volume":"120","author":"Farkas","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2010.10.012_bib23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0805538","article-title":"Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema","volume":"363","author":"Zuraw","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anai.2010.10.012_bib24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.amjmed.2005.09.064","article-title":"Hereditary angioedema: new findings concerning symptoms, affected organs, and course","volume":"119","author":"Bork","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.anai.2010.10.012_bib25","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1016\/j.jaci.2008.12.531","article-title":"Effect of hereditary angioedema: health-related quality of life, depression, productivity, and social consequences","volume":"123","author":"Wilson","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2010.10.012_bib26","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.anai.2010.01.024","article-title":"Economic costs associated with acute attacks and long-term management of hereditary angioedema","volume":"104","author":"Wilson","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2010.10.012_bib27","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archinte.163.10.1229","article-title":"Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency","volume":"163","author":"Bork","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.anai.2010.10.012_bib28","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMoa0906393","article-title":"Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema","volume":"363","author":"Cicardi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anai.2010.10.012_bib29","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa0905079","article-title":"Ecallantide for the treatment of acute attacks in hereditary angioedema","volume":"363","author":"Cicardi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anai.2010.10.012_bib30","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1742-1241.2005.00352.x","article-title":"Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence?","volume":"59","author":"Longhurst","year":"2005","journal-title":"Int J Clin Pract"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120610009567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120610009567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:38:47Z","timestamp":1761050327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120610009567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1081120610009567"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2010.10.012","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2010.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}